<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362916">
  <stage>Registered</stage>
  <submitdate>17/08/2012</submitdate>
  <approvaldate>21/08/2012</approvaldate>
  <actrnumber>ACTRN12612000890831</actrnumber>
  <trial_identification>
    <studytitle>West Australian Restrictive versus Liberal fluid in patients undergoing Major Elective Surgery</studytitle>
    <scientifictitle>Major Abdominal Surgery Restrictive versus Liberal Fluid Regimes  and Length of Stay in patients undergoing major elective abdominal surgery</scientifictitle>
    <utrn />
    <trialacronym>WA-RELIEF</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Major Abdominal Surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will be randomised to receive either a high or low volume perioperative intravenous fluid protocol. The use of goal directed devices will be controlled for in the statistical analysis, but their use is not part of the actual protocol . The Restrictive group will be considered the Control group for the purpose of the study design. The Liberal group will receive 10mls / kg at induction, 8 mls per kg per hour intraoperatively, and then 1.5 mls per kilogram intravenously postoperatively. The intention is to cease all fluids ASAP.</interventions>
    <comparator>There will be no "Control" group per se. For the purpose of the statistical analysis and study design the "Restrictive group" will be considered as the "Control". The Restrictive group will receive 5mls/kg at induction, &lt; 5mls / kg / hour for maintenance and &lt; 1 ml per kg post op.</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Hospital Length of Stay is the primary outcome and will be prospectively observed from admission to primary discharge. On the last day of hospital admission, research nursing staff following up patients on the ward will indicate Yes or No as to whether the patient is in hospital. The difference in days will then be considered the period of hospitalisation</outcome>
      <timepoint>At end of hospital stay</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Perioperative complications- comprising :

Respiratory and infective complications will be assessed and the CDC operational definitions of these complications will be employed</outcome>
      <timepoint>At end of hospital stay, at thirty day follow up and at one year.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Elective Major Abdominal Surgery
At least one night in hospital
High Surgical Risk</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Renal Failure
Coagulopathy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Random number generator will be used to generate sequence, with cluster randomisation per centre. Liberal and Restrictive groups will be allocated in a 1:1 overall ratio . The opaque sealaed envelope technique will be used to Single-blinded</concealment>
    <sequence>Random number generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Clustered per centre</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>1/09/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>6000</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Health Department of Western Australia</primarysponsorname>
    <primarysponsoraddress>Department of Health 
189 Royal Street 
East Perth WA 6004 
Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>State Health Research Advisory Committee, WA</fundingname>
      <fundingaddress>Department of Health 
189 Royal Street 
East Perth WA 6004 
Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine whether the administration of large or small volumes of fluid to patients underoing major elective abdominal surgery influences lenght of stay and outcome</summary>
    <trialwebsite>None</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee -Royal Perth Hospital</ethicname>
      <ethicaddress>Wellington Street
Perth
6000</ethicaddress>
      <ethicapprovaldate>1/11/2011</ethicapprovaldate>
      <hrec>RA-11/035</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Tomas Corcoran</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth 
WA 6000</address>
      <phone>+61 8 92241038</phone>
      <fax>+61 8 92241111</fax>
      <email>tomas.corcoran@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Tomas Corcoran</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth 
WA 6000</address>
      <phone>+61 8 92241038</phone>
      <fax>+61 8 92241111</fax>
      <email>tomas.corcoran@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Tomas Corcoran</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth 
WA 6000</address>
      <phone>+61 8 92241038</phone>
      <fax>+61 8 92241111</fax>
      <email>tomas.corcoran@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>